Capital Investment Advisory Services’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Capital Investment Advisory Services’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-30	Closed	-$3K	–	1374
2019 Q3	$3K	Hold	30	–	–	﹤0.01%	1244
2019 Q2	$5K	Buy	+30	New	+$5.19K	﹤0.01%	1158

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MGIM

M&G Investment Management London, United Kingdom $28.2B AUM 25.87% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Investment Advisory Services's GWPH Position: Q4 2019 in Review

Capital Investment Advisory Services sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2019, closing a stake of 30 shares — an estimated $3K sold.

Capital Investment Advisory Services first reported a position in GWPH in Q2 2019 and held it in 2 quarters. The position peaked at $5K in Q2 2019. 318 funds tracked by Wall St. Rank hold GWPH as of Q4 2019.

Capital Investment Advisory Services reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2019 after selling out during the quarter.
Capital Investment Advisory Services sold 30 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2019, an estimated $3K.
Capital Investment Advisory Services first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2019 and held it in 2 quarters.
Capital Investment Advisory Services's GW Pharmaceuticals Plc American Depositary Shares position peaked at $5K in Q2 2019.
318 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2019.

Based on Capital Investment Advisory Services's 13F filing for Q4 2019, filed 4 Feb 2020.